Compile Data Set for Download or QSAR
Report error Found 56 Enz. Inhib. hit(s) with all data for entry = 9627
TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 294112BDBM294112(US9585881, Example 99 | methyl [4-(2-{(2S,4S)-1-[(...)
Affinity DataIC50: 1.20nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238259BDBM238259(US9394250, 71 | US9585881, Example 71 | US10336741...)
Affinity DataIC50: 2.20nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238268BDBM238268(US9394250, 98 | US9585881, Example 98 | US10336741...)
Affinity DataIC50: 2.30nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238252BDBM238252(US9394250, 20 | US9585881, Example 20 | US10336741...)
Affinity DataIC50: 3.20nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238266BDBM238266(US9394250, 96 | US9585881, Example 96 | US10882855...)
Affinity DataIC50: 4.20nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238260BDBM238260(US9394250, 73 | US9585881, Example 73 | US10336741...)
Affinity DataIC50: 4.40nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238265BDBM238265(US9394250, 94 | US9585881, Example 94 | US10336741...)
Affinity DataIC50: 5.40nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238263BDBM238263(US9394250, 88 | US9585881, Example 88 | US10336741...)
Affinity DataIC50: 5.40nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238261BDBM238261(US9394250, 79 | US9585881, Example 79 | US10336741...)
Affinity DataIC50: 6.5nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238258BDBM238258(US9394250, 69 | US9585881, Example 69 | US10882855...)
Affinity DataIC50: 7.40nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238269BDBM238269(US9394250, 111 | US10336741, Example 111 | US10882...)
Affinity DataIC50: 8.5nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 294104BDBM294104(US9585881, Example 86 | methyl [4-(2-{(2S,4R)-1-({...)
Affinity DataIC50: 9.90nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238255BDBM238255(US9394250, 43 | US9585881, Example 43 | US10336741...)
Affinity DataIC50: 11nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238253BDBM238253(US9394250, 37 | US9585881, Example 37 | US10336741...)
Affinity DataIC50: 13nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238256BDBM238256(US9394250, 55 | US9585881, Example 55 | US10336741...)
Affinity DataIC50: 14nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238251BDBM238251(US9394250, 9 | US9585881, Example 9 | US10336741, ...)
Affinity DataIC50: 17nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238264BDBM238264(US9394250, 93 | US9585881, Example 93 | US10336741...)
Affinity DataIC50: 18nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238257BDBM238257(US9394250, 57 | US9585881, Example 57 | US10336741...)
Affinity DataIC50: 27nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor XI(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238254BDBM238254(US9394250, 39 | US9585881, Example 39 | US10882855...)
Affinity DataIC50: 78nMAssay Description:Human Factor XIa (Haematologic Technologies Inc.) activity was measured at an enzyme concentration of 0.1 U/mL in 150 mM NaCl, 5 mM KCl, 1 mg/mL PEG6...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238265BDBM238265(US9394250, 94 | US9585881, Example 94 | US10336741...)
Affinity DataIC50: 3.30E+4nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238265BDBM238265(US9394250, 94 | US9585881, Example 94 | US10336741...)
Affinity DataIC50: 3.30E+4nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238260BDBM238260(US9394250, 73 | US9585881, Example 73 | US10336741...)
Affinity DataIC50: 3.70E+4nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238261BDBM238261(US9394250, 79 | US9585881, Example 79 | US10336741...)
Affinity DataIC50: 4.00E+4nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238263BDBM238263(US9394250, 88 | US9585881, Example 88 | US10336741...)
Affinity DataIC50: 5.70E+4nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 294112BDBM294112(US9585881, Example 99 | methyl [4-(2-{(2S,4S)-1-[(...)
Affinity DataIC50: 8.40E+4nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238259BDBM238259(US9394250, 71 | US9585881, Example 71 | US10336741...)
Affinity DataIC50: 9.40E+4nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238256BDBM238256(US9394250, 55 | US9585881, Example 55 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238255BDBM238255(US9394250, 43 | US9585881, Example 43 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238255BDBM238255(US9394250, 43 | US9585881, Example 43 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238254BDBM238254(US9394250, 39 | US9585881, Example 39 | US10882855...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238254BDBM238254(US9394250, 39 | US9585881, Example 39 | US10882855...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238253BDBM238253(US9394250, 37 | US9585881, Example 37 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238253BDBM238253(US9394250, 37 | US9585881, Example 37 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238252BDBM238252(US9394250, 20 | US9585881, Example 20 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238252BDBM238252(US9394250, 20 | US9585881, Example 20 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238251BDBM238251(US9394250, 9 | US9585881, Example 9 | US10336741, ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238251BDBM238251(US9394250, 9 | US9585881, Example 9 | US10336741, ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 294104BDBM294104(US9585881, Example 86 | methyl [4-(2-{(2S,4R)-1-({...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 294104BDBM294104(US9585881, Example 86 | methyl [4-(2-{(2S,4R)-1-({...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238261BDBM238261(US9394250, 79 | US9585881, Example 79 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238260BDBM238260(US9394250, 73 | US9585881, Example 73 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238258BDBM238258(US9394250, 69 | US9585881, Example 69 | US10882855...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238258BDBM238258(US9394250, 69 | US9585881, Example 69 | US10882855...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238257BDBM238257(US9394250, 57 | US9585881, Example 57 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238257BDBM238257(US9394250, 57 | US9585881, Example 57 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238256BDBM238256(US9394250, 55 | US9585881, Example 55 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238268BDBM238268(US9394250, 98 | US9585881, Example 98 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238268BDBM238268(US9394250, 98 | US9585881, Example 98 | US10336741...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetCoagulation factor X(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238266BDBM238266(US9394250, 96 | US9585881, Example 96 | US10882855...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

TargetProthrombin(Human)
Ono Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 238266BDBM238266(US9394250, 96 | US9585881, Example 96 | US10882855...)
Affinity DataIC50: 1.00E+5nMAssay Description:Human Factor Xa (American Diagnostica Inc.) and human thrombin (Sigma) activities were measured at the enzyme concentrations of 0.18 U/mL and 0.12 U/...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2021
Entry Details
US Patent

Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: